United States · Funded startup

Who invested in BioTime

9 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$107Mraised across 9 rounds since 2009, from 9 sources

$3.4MDebt$8.0MVenture$61KVenture$8.0MVenture$3.5MSeries A$6.4MRound$31MRound$3.3MRound$43MRound
Latest round
Round, $43MAug 2018
Step-upi
13×
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20092011201320152017
$3.4MDebt$8.0MVenture$61KVenture$8.0MVenture$3.5MSeries A$6.4MRound$3.3MRound$43MRound
First round
Debt, $3.4M
Apr 2009
Biggest round
$43M
Round · Aug 2018
Usual gap between rounds
11 months
the median of 6

The rounds

  1. Aug 2018
    Round$43M1 new

    Reported by FinSMEs

  2. May 2015
    Round$3.3M

    No investor was named in the report.

    From a historical funding record

  3. Oct 2014
    Round$31M

    No investor was named in the report.

    From a historical funding record

  4. May 2014
    Round$6.4M

    No investor was named in the report.

    From a historical funding recordSEC filing: $3.5M sold, first sale Mar 2014

  5. Mar 2014
    Series A$3.5M

    No investor was named in the report.

    From a historical funding recordSEC filing: $3.5M sold, first sale Mar 2014

  6. May 2010
    Venture$8.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $61K sold, first sale Apr 2010

  7. Apr 2010
    Venture$61K

    No investor was named in the report.

    Reported by sec.govSEC filing: $61K sold, first sale Apr 2010

  8. May 2009
    Venture$8.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $4.0M sold, first sale May 2009

  9. Apr 2009
    Debt$3.4M

    No investor was named in the report.

    From a historical funding recordSEC filing: $3.4M sold, first sale Apr 2009

Founders and team

From the SEC filings it signed: 3 on the team.

  • Michael D WestExecutive Officer, Directori
  • Robert W PeabodyExecutive Officeri
  • William P. TewExecutive Officeri

On the board, as filediAlfred D KingsleyAndrew C. von EschenbachFranklin M. BergerHenry L. NordhoffJudith D SegallNeal C BradsherPedro D LichtingerStephen C. Farrell

Everyone who backed them

JuvenescenceVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about BioTime

Who invested in BioTime?

BioTime's investors include Juvenescence.

How much has BioTime raised?

BioTime has raised $107M across 9 rounds since 2009.

When did BioTime last raise?

BioTime's most recent round was an Undisclosed round of $43M in Aug 2018.

What was BioTime's biggest round?

Its most recent round, $43M in Aug 2018, is also its largest on record.

Who backed BioTime first?

BioTime's first round on record, in Aug 2018, was backed by Juvenescence.

What stage is BioTime at?

BioTime's latest named round is an Undisclosed round, in Aug 2018.

Where is BioTime based?

BioTime is based in the United States.

Companies like BioTime

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.